ArticleClinical research in cardiology : official journal of the German Cardiac Society2025
Postinterventional surveillance at a dedicated valve unit is safe and reduces intensive care utilization after TAVR.
Article in Clinical research in cardiology : official journal of the German Cardiac Society, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Response to "Beyond the three-risk-factor model: unmeasured confounders and residual vulnerability in post-TAVI ICU triage".Heart and vessels · 2026Article
- Beyond the three-risk-factor model: unmeasured confounders and residual vulnerability in post-TAVI ICU triage.Heart and vessels · 2026Article
- Association between frailty and long-term outcomes in patients undergoing TAVI admitted to private intensive care units in Australia.Critical care and resuscitation : journal of the Australasian Academy of Critical Care Medicine · 2026Article
- Intensive care utilization and clinical outcomes after transcatheter aortic valve implantation: a nationwide observational study using the Japanese intensive care patient database.Heart and vessels · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe postprocedural care pathway after transcatheter aortic valve replacement (TAVR) mostly includes monitoring patients for 24-48 h at an intensive care unit (ICU) or intermediate care unit (routine intensive care monitoring = ICM). To reduce the need for postprocedural intensive care surveillance, our center established a dedicated monitoring unit (valve unit = VU) for pre- and postprocedural care of TAVR patients.
methodsThe aim of this prospective case-control study was to evaluate outcomes of patients directly before and after the introduction of the VU. Starting in April 2020 TAVR patients were directly transferred to a VU after the procedure with 24-h telemetric electrocardiogram (ECG) and non-invasive blood pressure monitoring, which was spatially integrated into a general cardiology ward. Patients with hemodynamic or respiratory instability, stroke, delirium, and severe bleeding complications were still directly transferred to the ICU.
results796 consecutive patients treated with TAVR at our center were included. 592 patients had been treated during ICM and 204 after the establishment of the VU. The overall rate of events was similar before and after the implementation of the valve unit. 182 of 592 ICM patients developed study-specific endpoints (30.7%) compared to 60 of 204 VU patients (29.4%) (P value for difference: 0.87). VU patients showed a trend towards a lower rate of delirium (ICM 3.5% vs VU 1%, p-value 0.06).
conclusionIntroduction of a VU for patient monitoring after TAVR with prespecified criteria for postinterventional ICU surveillance reduced the percentage of postinterventional ICU admissions by 73% without increasing the overall rate of adverse events.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.